Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 6.9% on Friday . The company traded as low as C$0.14 and last traded at C$0.14. 139,979 shares were traded during trading, an increase of 6% from the average session volume of 131,911 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Trading Down 10.3%
The company has a debt-to-equity ratio of -63.20, a quick ratio of 6.67 and a current ratio of 0.08. The stock has a market cap of C$24.40 million, a P/E ratio of -4.33 and a beta of -0.92. The company has a 50-day simple moving average of C$0.11 and a 200-day simple moving average of C$0.11.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
